Skip to main content

Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.

Publication ,  Journal Article
Autmizguine, J; Tan, S; Cohen-Wolkowiez, M; Cotten, CM; Wiederhold, N; Goldberg, RN; Adams-Chapman, I; Stoll, BJ; Smith, PB; Benjamin, DK ...
Published in: Pediatr Infect Dis J
September 2018

BACKGROUND: Invasive candidiasis is an important cause of sepsis in extremely low birth weight infants (ELBW, < 1000 g), is often fatal, and frequently results in neurodevelopmental impairment (NDI) among survivors. We sought to assess the antifungal minimum inhibitory concentration (MIC) distribution for Candida in ELBW infants and evaluate the association between antifungal resistance and death or NDI. METHODS: This was a secondary analysis of a National Institute of Child Health and Human Development Neonatal Research Network study. MIC values were determined for fluconazole, amphotericin B and micafungin. NDI was assessed at 18-22 months adjusted age using the Bayley Scales of Infant Development. An infant was defined as having a resistant Candida isolate if ≥ 1 positive cultures from normally sterile sites (blood, cerebrospinal fluid, or urine) were resistant to ≥ 1 antifungal agent. In addition to resistance status, we categorized fungal isolates according to MIC values (low and high). The association between death/NDI and MIC level was determined using logistic regression, controlling for gestational age and Bayley Scales of Infant Development (II or III). RESULTS: Among 137 ELBW infants with IC, MICs were determined for 308 isolates from 110 (80%) infants. Three Candida isolates from 3 infants were resistant to fluconazole. None were resistant to amphotericin B or micafungin. No significant difference in death, NDI, or death/NDI between groups with low and high MICs was observed. CONCLUSIONS: Antifungal resistance was rare among infecting Candida isolates, and MIC level was not associated with increased risk of death or NDI in this cohort of ELBW infants.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Infect Dis J

DOI

EISSN

1532-0987

Publication Date

September 2018

Volume

37

Issue

9

Start / End Page

923 / 929

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sepsis
  • Prospective Studies
  • Pediatrics
  • Neurodevelopmental Disorders
  • Microbial Sensitivity Tests
  • Micafungin
  • Male
  • Intensive Care Units, Neonatal
  • Infant, Newborn, Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Autmizguine, J., Tan, S., Cohen-Wolkowiez, M., Cotten, C. M., Wiederhold, N., Goldberg, R. N., … NICHD Neonatal Research Network, . (2018). Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis. Pediatr Infect Dis J, 37(9), 923–929. https://doi.org/10.1097/INF.0000000000001913
Autmizguine, Julie, Sylvia Tan, Michael Cohen-Wolkowiez, C Michael Cotten, Nathan Wiederhold, Ronald N. Goldberg, Ira Adams-Chapman, et al. “Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.Pediatr Infect Dis J 37, no. 9 (September 2018): 923–29. https://doi.org/10.1097/INF.0000000000001913.
Autmizguine J, Tan S, Cohen-Wolkowiez M, Cotten CM, Wiederhold N, Goldberg RN, et al. Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis. Pediatr Infect Dis J. 2018 Sep;37(9):923–9.
Autmizguine, Julie, et al. “Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.Pediatr Infect Dis J, vol. 37, no. 9, Sept. 2018, pp. 923–29. Pubmed, doi:10.1097/INF.0000000000001913.
Autmizguine J, Tan S, Cohen-Wolkowiez M, Cotten CM, Wiederhold N, Goldberg RN, Adams-Chapman I, Stoll BJ, Smith PB, Benjamin DK, NICHD Neonatal Research Network. Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis. Pediatr Infect Dis J. 2018 Sep;37(9):923–929.

Published In

Pediatr Infect Dis J

DOI

EISSN

1532-0987

Publication Date

September 2018

Volume

37

Issue

9

Start / End Page

923 / 929

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sepsis
  • Prospective Studies
  • Pediatrics
  • Neurodevelopmental Disorders
  • Microbial Sensitivity Tests
  • Micafungin
  • Male
  • Intensive Care Units, Neonatal
  • Infant, Newborn, Diseases